{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:05:17Z","timestamp":1778875517006,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.arcmed.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T18:17:02Z","timestamp":1667499422000},"page":"658-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tumor-augmenting Effect of Histone Methyltransferase WHSC1 on Colorectal Cancer Via Epigenetic Upregulation of TACC3 and PI3K\/Akt Activation"],"prefix":"10.1016","volume":"53","author":[{"given":"Yuejuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-4742","authenticated-orcid":false,"given":"Lizhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2022.10.006_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"64","key":"10.1016\/j.arcmed.2022.10.006_bib0002","first-page":"252","article-title":"Cancer treatment and survivorship statistics","volume":"2014","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","article-title":"ACLY facilitates colon cancer cell metastasis by CTNNB1","volume":"38","author":"Wen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.prp.2015.05.010","article-title":"Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review","volume":"211","author":"Cao","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2018.03.038","article-title":"Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression","volume":"425","author":"Jiang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0006","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2018.01.049","article-title":"Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications","volume":"419","author":"Porcellini","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0007","doi-asserted-by":"crossref","first-page":"34283","DOI":"10.1074\/jbc.M109.034462","article-title":"The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001374","article-title":"WHSC1\/NSD2 regulates immune infiltration in prostate cancer","volume":"9","author":"Want","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0009","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.2147\/OTT.S204701","article-title":"WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer","volume":"12","author":"Wu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10799893.2020.1747490","article-title":"WHSC1 promotes wnt\/beta-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer","volume":"40","author":"Zhang","year":"2020","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-021-00402-6","article-title":"Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41419-017-0112-6","article-title":"TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer","volume":"9","author":"Lin","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111952","article-title":"TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formation","volume":"390","author":"Qie","year":"2020","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0014","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1535-7163.MCT-19-0957","article-title":"A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate","volume":"19","author":"Akbulut","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2013.01.013","article-title":"TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K\/Akt and ERK signaling pathways","volume":"332","author":"Ha","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0016","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biocel.2019.02.010","article-title":"Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer","volume":"110","author":"Parizadeh","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0018","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.2147\/OTT.S248570","article-title":"WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling","volume":"13","author":"Dai","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0019","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12885-019-5638-9","article-title":"The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation","volume":"19","author":"Kojima","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbrc.2021.06.034","article-title":"Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis","volume":"567","author":"Liu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0021","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1541-7786.MCR-14-0292-T","article-title":"WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck","volume":"13","author":"Saloura","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0022","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1016\/j.molcel.2021.08.034","article-title":"NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis","volume":"81","author":"Sengupta","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0023","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bbrc.2018.03.125","article-title":"Inhibition of TACC3 by a small molecule inhibitor in breast cancer","volume":"498","author":"Campo","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0024","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.18632\/aging.101585","article-title":"Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy","volume":"10","author":"Ma","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13277-015-3810-7","article-title":"Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with \"stemness\" and epithelial-mesenchymal transition-related marker expression and a poor prognosis","volume":"37","author":"Nahm","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0026","doi-asserted-by":"crossref","first-page":"e70353","DOI":"10.1371\/journal.pone.0070353","article-title":"TACC3 is essential for EGF-mediated EMT in cervical cancer","volume":"8","author":"Ha","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0027","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1389450120666190618123846","article-title":"PI3K\/Akt\/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.arcmed.2022.10.006_bib0028","first-page":"568","article-title":"Recent clinical advances in PI3K inhibitors on colorectal cancer","volume":"76","author":"Zhu","year":"2021","journal-title":"Pharmazie"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:51:28Z","timestamp":1759261888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440922001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0188440922001278"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.10.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-augmenting Effect of Histone Methyltransferase WHSC1 on Colorectal Cancer Via Epigenetic Upregulation of TACC3 and PI3K\/Akt Activation","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}